CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,825,450 | -15.6% | 503,240 | -6.5% | 0.10% | -17.3% |
| Q2 2023 | $17,557,389 | +0.7% | 538,240 | 0.0% | 0.13% | +5.0% |
| Q1 2023 | $17,433,536 | -24.4% | 538,240 | +7.0% | 0.12% | -22.4% |
| Q4 2022 | $23,057,377 | -5.4% | 503,240 | 0.0% | 0.16% | -9.3% |
| Q3 2022 | $24,383,000 | +19.2% | 503,240 | -3.3% | 0.17% | +2.4% |
| Q2 2022 | $20,449,000 | -13.2% | 520,476 | -18.7% | 0.17% | +5.0% |
| Q1 2022 | $23,566,000 | +0.7% | 640,228 | +24.7% | 0.16% | +7.4% |
| Q4 2021 | $23,398,000 | +27.5% | 513,344 | 0.0% | 0.15% | +19.2% |
| Q3 2021 | $18,346,000 | +80.6% | 513,344 | 0.0% | 0.12% | +78.6% |
| Q2 2021 | $10,159,000 | +35.4% | 513,344 | +36.6% | 0.07% | +12.9% |
| Q1 2021 | $7,502,000 | -4.0% | 375,853 | 0.0% | 0.06% | 0.0% |
| Q4 2020 | $7,811,000 | +157.3% | 375,853 | +168.0% | 0.06% | +113.8% |
| Q3 2020 | $3,036,000 | – | 140,225 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |